Authors:
Henry, SP
Miner, RC
Drew, WL
Fitchett, J
York-Defalco, C
Rapp, LM
Levin, AA
Citation: Sp. Henry et al., Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication, INV OPHTH V, 42(11), 2001, pp. 2646-2651
Authors:
Takanosu, M
Boyd, TC
Le Goff, M
Henry, SP
Zhang, YW
Bishop, PN
Mayne, R
Citation: M. Takanosu et al., Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene, INV OPHTH V, 42(10), 2001, pp. 2202-2210
Authors:
Detrick, B
Nagineni, CN
Grillone, LR
Anderson, KP
Henry, SP
Hooks, JJ
Citation: B. Detrick et al., Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides, INV OPHTH V, 42(1), 2001, pp. 163-169
Authors:
Henry, SP
Takanosu, M
Boyd, TC
Mayne, PM
Eberspaecher, H
Zhou, W
de Crombrugghe, B
Hook, M
Mayne, R
Citation: Sp. Henry et al., Expression pattern and gene characterization of asporin - A newly discovered member of the leucine-rich repeat protein family, J BIOL CHEM, 276(15), 2001, pp. 12212-12221
Authors:
Geary, RS
Yu, RZ
Leeds, JM
Watanabe, TA
Henry, SP
Levin, AA
Templin, MV
Citation: Rs. Geary et al., Pharmacokinetic properties in animals, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 119-154
Authors:
Levin, AA
Henry, SP
Monteith, D
Templin, MV
Citation: Aa. Levin et al., Toxicity of antisense oligonucleotides, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 201-267
Authors:
Leeds, JM
Henry, SP
Geary, R
Burckin, T
Levin, AA
Citation: Jm. Leeds et al., Comparison of the pharmacokinetics of subcutaneous and intravenous administration of a phosphorothioate oligodeoxynucleotide in cynomolgus monkeys, ANTISENSE N, 10(6), 2000, pp. 435-441
Authors:
Henry, SP
Templin, MV
Gillett, N
Rojko, J
Levin, AA
Citation: Sp. Henry et al., Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1, TOX PATHOL, 27(1), 1999, pp. 95-100